Public Funding as a Foundation for Innovation
Our development is supported by two key public funding instruments:
A Strong Ecosystem for Innovation and Growth
As part of the Accent incubation program in Lower Austria, we benefit from a high-tech ecosystem specifically tailored to life science startups. Accent supports us strategically and operationally – from IP management to investor outreach. Our experimental and software-driven R&D takes place at the MakerSpace in Tulln, a fully equipped lab and prototyping facility that enables in-house testing and agile development cycles.
Through the BSV incubation program, we receive additional coaching, access to expert networks, and capital market–oriented resources to prepare for market entry and commercialization. Participation in the Panacea Initiative further integrates RNAnalytics into a Europe-wide network for RNA and LNP innovation – bringing together partners from academia, industry, and policy.
These partnerships are not just support structures – they are strategic levers. They enable us to unite scientific validity, regulatory relevance, and industrial scalability into an integrated technology platform – with the goal of redefining the standards of LNP analytics.